hepatitis C

Gilead-Bristol Hepatitis C Drug Combo Cures 100% in Study
Bloomberg
Sun, 04/28/13 - 12:04 pm
Gilead Sciences
Bristol-Myers Squibb
hepatitis C
hepatitis
sofosbuvir
daclatasvir
Bristol Still Playing Catch-Up To Gilead In Hep C Drug Race
TheStreet.com
Tue, 04/23/13 - 11:21 am
Gilead
Bristol-Myers Squibb
hepatitis C
sofosbuvir
daclatasvir
asunaprevir
BMS-791325
Gilead announces results from Phase 3 trial evaluating sofosbuvir
Yahoo/Fly on the Wall
Tue, 04/23/13 - 11:06 am
Gilead
hepatitis C
sofosbuvir
Bristol-Myers Hepatitis C Combo Therapy Blunts Disease
Bloomberg
Tue, 04/23/13 - 08:48 am
BMS-791325
Bristol-Myers Squibb
hepatitis C
daclatasvir
asunaprevir
Merck's Experimental Hepatitis C Drug Beats Victrelis
Bloomberg
Tue, 04/23/13 - 08:42 am
Victrelis
hepatitis C
Merck
MK-5172
Achillion Says Hepatitis C Drug Subdues Virus in 63% of Patients
Bloomberg
Tue, 04/23/13 - 07:57 am
hepatitis C
Achillion
ACH-3102
AbbVie hepatitis C drugs knock out virus at 8 weeks
Reuters
Tue, 04/23/13 - 07:50 am
hepatitis C
AbbVie
ABT-450
ABT-333
ABT-267
Merck, Bristol-Myers will test hepatitis C regimen
Yahoo/AP
Mon, 04/22/13 - 10:54 am
hepatitis C
Merck
Bristol-Myers Squibb
MK-5172
daclatasvir
Roche in hepatitis C drug deal with Ascletis in China
Reuters
Mon, 04/15/13 - 09:39 am
Roche
China
Ascletis Pharmaceuticals
hepatitis C
Pegasys
Gilead submits NDA to FDA for sofosbuvir for the treatment of HCV
Yahoo/Fly on the Wall
Tue, 04/9/13 - 10:45 am
sofosbuvir
Gilead
hepatitis C
Inovio's Hepatitis C Data: What Does It Really Mean?
Seeking Alpha
Fri, 04/5/13 - 11:04 am
Inovio
hepatitis C
ChronTech AB
ChronVac-C
vaccines
Vertex, Bristol-Myers enter agreement for Phase 2 studies of VX-135, daclatasvir
Yahoo/Fly on the Wall
Fri, 04/5/13 - 10:25 am
VX-135
Vertex Pharmaceuticals
Bristol-Myers Squibb
daclatasvir
hepatitis C
Gilead's HCV Study to Continue
Yahoo/Zacks
Tue, 04/2/13 - 10:10 am
hepatitis C
Gilead
sofosbuvir
ledipasvir
Idenix Loses First Phase Of Patent Dispute With Gilead Sciences
TheStreet.com
Mon, 03/25/13 - 12:05 pm
Gilead
Idenix
patents
hepatitis C
sofosbuvir
Idenix Pharmaceuticals Announces Decision by the United States Patent and Trademark Office Patent Trial and Appeal Board
Yahoo/GlobeNewsWire
Sat, 03/23/13 - 08:52 am
Gilead Pharmasset
Idenix
hepatitis C
patents
BioLineRx to Initiate HCV Study
Yahoo/Zacks
Sat, 03/16/13 - 10:40 am
BioLineRx
HCV
BL-8020
hepatitis C
Vertex: The Sun Sets On Incivek, Rises On Its CF Franchise
Seeking Alpha
Fri, 03/15/13 - 10:57 am
Incivek
Vertex Pharmaceuticals
Gilead
GSK
JNJ
Kalydeco
cystic fibrosis
hepatitis C
Boehringer signs hep C pact with Presidio
Pharma Times, UK
Thu, 03/14/13 - 10:56 am
hepatitis C
Presidio Pharmaceuticals
Boehringer Ingelheim
Pfizer Halts Production Of Hepatitis C Drug
Wall Street Cheat Street
Sat, 03/9/13 - 12:26 pm
Pfizer
hepatitis C
Filibuvir
Gilead-Medivir Hepatitis C Drug Clears Virus in Patients
Bloomberg
Mon, 03/4/13 - 10:59 am
hepatitis C
Gilead
Medivir
sofosbuvir
simeprevir

Pages